SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-14-000704
Filing Date
2014-07-03
Accepted
2014-07-03 21:37:16
Documents
1
Period of Report
2014-07-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4082
  Complete submission text file 0001123292-14-000704.txt   5517
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 400 BRISBANE CA 94005 650-745-7802
HYPERION THERAPEUTICS INC (Issuer) CIK: 0001386858 (see all company filings)

IRS No.: 611512713 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HYPERION THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005
Business Address
Scharschmidt Bruce Frederick (Reporting) CIK: 0001554402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35614 | Film No.: 14961909